Work

Efficacy and safety of TIPS versus endoscopic therapy with NSBBs for schistosomiasis-related variceal rebleeding

Year: 2026
Type: article
Study design: Observational Study
Abstract: Hepatosplenic schistosomiasis affects about 4–8% of individuals with schistosomal infection. Upper gastrointestinal bleeding (UGB) is the most common complication of schistosomiasis-induced liver fibrosis. This study aimed to compare the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy combined with nonselective beta-blockers (EC-NSBBs) for secondary prevention of schistosomiasis-related variceal bleeding. We retrospectively analyzed 67 patients with schistosomal liver disease and a history of gastroesophageal variceal bleeding. 37 patients underwent TIPS creation, while 30 patients received endoscopic therapy combined with NSBBs. The rates of variceal rebleeding, overt hepatic encephalopathy (OHE), and survival were compared between the two groups. The cumulative probability of variceal rebleeding was significantly lower in the TIPS group compared to the EC-NSBBs group (HR = 0.09, 95% CI: 0.03–0.31, Log-rank P < 0.01), with no significant differences between the two groups in terms of OHE ( P = 0.38) and survival rates ( P = 0.94). In the TIPS group, portal vein thrombosis, ascites, and pleural effusion gradually decreased after 6 months. Multivariate Cox analysis identified treatment modality, CTP score, and variceal diameter as predictors of variceal rebleeding. TIPS significantly reduces the rebleeding rate in patients with schistosomiasis-related varices with a favorable safety profile.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W7236708084
FWCI:
Cites:
Cited by:
Related to: 10